Romiplostim is an Fc-peptide fusion antibody and thrombopoietin (TPO) agonist. It enhances platelet production by activating the TPO receptor, thereby stimulating JAK/STAT, MAPK pathways, and multiple anti-apoptotic pathways. It is indicated for the treatment of immune thrombocytopenic purpura (ITP).
Purity:
0.97
CAS Number:
[267639-76-9]
Target:
Apoptosis|||JAK|||STAT|||MAPK|||Thrombin
* VAT and and shipping costs not included. Errors and price changes excepted